(20S)-Protopanaxdiol structure
|
Common Name | (20S)-Protopanaxdiol | ||
---|---|---|---|---|
CAS Number | 30636-90-9 | Molecular Weight | 460.732 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 559.5±40.0 °C at 760 mmHg | |
Molecular Formula | C30H52O3 | Melting Point | 211 °C | |
MSDS | N/A | Flash Point | 226.1±21.9 °C |
Use of (20S)-Protopanaxdiol(20S)-Protopanaxadiol (20-Epiprotopanaxadiol) is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin; apoptosis inducer.IC50 value:Target: apoptosis inducer(20S)-Protopanaxadiol was used to induce cytotoxicity for two human glioma cell lines, SF188 and U87MG. For the SF188 cells, (20S)-Protopanaxadiol activated caspases-3, -8, -7, and -9 within 3 h and induced rapid apoptosis, which could be partially inhibited by a general caspase blocker and completely abolished when the caspase blocker was used in combination with an antioxidant. (20S)-Protopanaxadiol also induced cell death in U87MG cells but did not activate any caspases in these cells [1]. aPPD was able to inhibit P-gp activity as potently as verapamil on MDR cells. The blockage of P-gp activity was highly reversible as wash-out of aPPD resulted in an immediate recovery of P-gp activity. Unlike verapamil, aPPD did not affect ATPase activity of P-gp suggesting a different mechanism of action [2]. |
Name | (20S)-protopanaxadiol |
---|---|
Synonym | More Synonyms |
Description | (20S)-Protopanaxadiol (20-Epiprotopanaxadiol) is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin; apoptosis inducer.IC50 value:Target: apoptosis inducer(20S)-Protopanaxadiol was used to induce cytotoxicity for two human glioma cell lines, SF188 and U87MG. For the SF188 cells, (20S)-Protopanaxadiol activated caspases-3, -8, -7, and -9 within 3 h and induced rapid apoptosis, which could be partially inhibited by a general caspase blocker and completely abolished when the caspase blocker was used in combination with an antioxidant. (20S)-Protopanaxadiol also induced cell death in U87MG cells but did not activate any caspases in these cells [1]. aPPD was able to inhibit P-gp activity as potently as verapamil on MDR cells. The blockage of P-gp activity was highly reversible as wash-out of aPPD resulted in an immediate recovery of P-gp activity. Unlike verapamil, aPPD did not affect ATPase activity of P-gp suggesting a different mechanism of action [2]. |
---|---|
Related Catalog | |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 559.5±40.0 °C at 760 mmHg |
Melting Point | 211 °C |
Molecular Formula | C30H52O3 |
Molecular Weight | 460.732 |
Flash Point | 226.1±21.9 °C |
Exact Mass | 460.391632 |
PSA | 60.69000 |
LogP | 7.59 |
Vapour Pressure | 0.0±3.5 mmHg at 25°C |
Index of Refraction | 1.529 |
Hazard Codes | Xi |
---|
Protopanaxadiol |
Protopanaxtriol |
(20S)-Protopanaxadiol |
20(S)-Protopanaxdiol |
(3β,12β)-Dammar-24-ene-3,12,20-triol |
PROTOPANAXDIOL |
Dammar-24-ene-3,12,20-triol, (3β,12β)- |
Protopanaxadiol, 20S- |